Harm Reduction Radio - HAMS

Our guest this evening is Eddie Einbinder, author of How To Have Fun And Not Die and producer of the film series Play Safe.

Our guest today is Lucy Rocca, founder of the social networking site Soberistas and co-author of The Sober Revolution: Women Calling Time on Wine o’clock.

Our guest this evening is Shane Schleger, author of the Slate article Fifteen Years Smoking Crack: Life in the middle ground between total abstinence and rock bottom and host of the podcast Dope Stories.

Our guest this evening is Katherine van Wormer, MSSW, Ph. D., professor of social work at the University of Northern Iowa and author of Addiction Treatment: A Strengths Perspective.

Our guest this evening is Lance Dodes, MD, author of The Sober Truth: Debunking the Bad Science Behind 12-Step Programs and the Rehab Industry. Dr. Dodes is a Training and Supervising analyst emeritus with the Boston Psychoanalytic Society and Institute and recently retired assistant clinical professor of psychiatry at Harvard Medical School.

Our guest today is Rachel Black, author of Sober is the New Black: A Then and Now Account of Life Beyond Booze.

Our guest this evening is Lynn Paltrow, JD, Executive Director of National Advocates for Pregnant Women. We will be discussing drug use and addiction during pregnancy and the Alicia Beltran case--a Wisconsin women jailed for refusing to take the opiate buprenorphine.

Our guest this evening is Pete Soderman, SMART facilitator and author of Powerless No Longer: Reprogramming Your Addictive Behavior.

Our guest this evening is Nicole Kosanke, PhD of the Center for Motivation and Change. She is a co-author, with Jeffry Foote and Carrie Wilkens, of Beyond Addiction: How Science and Kindness Help People Change. We will be discussing the CRAFT approach for working with loved ones who have addictions.

Our guest this afternoon is David Yusko, Psy D, co-author of the paper Concurrent naltrexone and prolonged exposure therapy for patients with comorbid alcohol dependence and PTSD: a randomized clinical trial.